1. Telix mediarelease27October2022. 2. ASXdisclosure14November2022. 3. Telixsocialmedia21December 2022. AboutTelix PharmaceuticalsLimited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals.TelixisheadquarteredinMelbourne, Australia withinternationaloperationsinUnitedStates, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of clinical-stage products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX). For more information visit www.telixpharma.comand follow Telix on LinkedIn. TLX250-CDx(89Zr-DFO-girentuximab)hasnotreceived amarketingauthorisationinanyjurisdiction.Telix'sleadproduct, Illuccixorkitforpreparationofgallium-68(68Ga)gozetotide(also knownas68GaPSMA-11)injection, hasbeenapproved by the U.S. Food and Drug Administration (FDA), 1 by the Australian Therapeutic Goods Administration (TGA), 2 and by Health Canada.3 TelixInvestor Relations Ms.KyahnWilliamson TelixPharmaceuticalsLimited SVPCorporateCommunicationsandInvestorRelations Email: [email protected] ThisannouncementhasbeenauthorisedforreleasebytheTelix PharmaceuticalsLimitedDisclosureCommitteeonbehalf of the Board. Legal Notices Thisannouncementisnotintended aspromotionoradvertisingdirected toanyhealthcareprofessionalorotheraudience in any country worldwide (including Australia, United States and the United Kingdom). This announcement may include forward-looking statements that relate to anticipated future events, financial performance, plans, strategies or business developments.Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "outlook", "forecast" and"guidance", orothersimilar words.Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on the Company's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect the Company's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but arenotlimitedto, statementsabout: theinitiation, timing, progressandresults ofTelix'spreclinicalandclinicalstudies, andTelix's researchanddevelopmentprograms;Telix'sability toadvanceproduct candidatesinto, enrol andsuccessfully complete, clinical studies, includingmulti-nationalclinicaltrials;thetimingorlikelihoodofregulatoryfilings andapprovals, manufacturing activities and product marketing activities; the commercialisation of Telix's product candidates, if or when theyhavebeenapproved;estimatesofTelix's expenses, futurerevenuesandcapitalrequirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may beadverse.Accordingly, youshouldnotplaceunduerelianceontheseforward-lookingstatements.Youshould read this announcement together with our risk factors, as disclosed in our most recently filed reports with the ASX or on our website. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to publicly update or revise any forward-lookingstatementscontained inthisannouncement, whetherasaresult ofnewinformation, futuredevelopments or a change in expectations or assumptions. TheTelix PharmaceuticalsandtheIlluccixnameandlogoaretrademarksofTelixPharmaceuticalsLimitedanditsaffiliates - all rights reserved. 1. ASXdisclosure20December2021. 2. ASXdisclosure2November2021. 3. ASXdisclosure14October2022 "/>

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Bulletin.

More Information
null in null

International

Section
Moscow removes Taliban from banned list, grants official status
Moscow removes Taliban from banned list, grants official status

MOSCOW, Russia: This week, Russia became the first country to officially recognize the Taliban as the government of Afghanistan since...

Netanyahu vows 'No Hamas' in postwar Gaza amid peace talks
Netanyahu vows 'No Hamas' in postwar Gaza amid peace talks

CAIRO, Egypt: This week, both Hamas and Israel shared their views ahead of expected peace talks about a new U.S.-backed ceasefire plan....

US sends message by publicizing visa ban on UK punk-rap band
US sends message by publicizing visa ban on UK punk-rap band

WASHINGTON, D.C.: The Trump administration has made public a visa decision that would usually be kept private. It did this to send...

Tragedy in Spain: Diogo Jota and his brother die in car accident
Tragedy in Spain: Diogo Jota and his brother die in car accident

MADRID, Spain: Liverpool footballer Diogo Jota and his younger brother, André Silva, have died in a car accident in Spain. Spanish...

Early heatwave grips Europe, leaving 8 dead and nations on alert
Early heatwave grips Europe, leaving 8 dead and nations on alert

LONDON, U.K.: An unrelenting heatwave sweeping across Europe has pushed early summer temperatures to historic highs, triggering deadly...

U.S. military, China, Russia in Space race
U.S. military, China, Russia in Space race

President Donald Trump's plans to build a space-based Golden Dome missile defense shield have drawn immediate criticism from China,...

Business

Section
US debt limit raised, but spending bill fuels fiscal concerns
US debt limit raised, but spending bill fuels fiscal concerns

NEW YORK CITY, New York: With just weeks to spare before a potential government default, U.S. lawmakers passed a sweeping tax and spending...

Shein hit with 40 million euro fine in France over deceptive discounts
Shein hit with 40 million euro fine in France over deceptive discounts

PARIS, France: Fast-fashion giant Shein has been fined 40 million euros by France's antitrust authority over deceptive discount practices...

Meta hires SSI CEO Gross as AI race intensifies among tech giants
Meta hires SSI CEO Gross as AI race intensifies among tech giants

PALO ALTO/TEL AVIV: The battle for top AI talent has claimed another high-profile casualty—this time at Safe Superintelligence (SSI),...

Engine defect prompts Nissan to recall over 443,000 vehicles
Engine defect prompts Nissan to recall over 443,000 vehicles

FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...

Microsoft trims jobs to manage soaring AI infrastructure costs
Microsoft trims jobs to manage soaring AI infrastructure costs

REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...

Stocks worldwide struggle to make ground Friday with Wall Street closed
Stocks worldwide struggle to make ground Friday with Wall Street closed

LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...

Movie Review